Dow Jones

39,069.59

0.01%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
USOTC
RegeneRX Biopharmaceuticals Inc (CE) (RGRX)
RegeneRX Biopharmaceuticals Inc (CE) (RGRX) Noticias

RGRX

RegeneRX Biopharmaceutic... (CE) (RGRX)

RegeneRX Biopharmaceuticals Inc (CE)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:RGRX

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
14/08/2023	15:01	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
07/08/2023	14:57	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
11/07/2023	16:13	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
06/07/2023	15:35	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
06/07/2023	15:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
26/06/2023	05:01	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
21/06/2023	05:03	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
15/05/2023	15:25	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
11/04/2023	15:32	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
19/05/2022	16:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
18/10/2021	05:05	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
17/08/2021	09:32	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
19/07/2021	15:16	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
08/02/2021	17:29	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
16/10/2020	15:17	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
18/08/2020	05:06	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
10/09/2019	16:06	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
07/03/2019	13:15	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
01/03/2019	15:42	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
24/10/2018	05:02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
23/10/2018	05:05	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
12/12/2017	11:35	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
14/08/2017	16:10	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
03/08/2016	05:03	Edgar (US Regulatory)	(DEL AM)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
30/03/2016	16:17	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
29/12/2014	12:42	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
01/04/2014	15:43	Edgar (US Regulatory)	Semi-annual Report (management Company) (nsar-a)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
01/04/2014	15:43	Edgar (US Regulatory)	Mutual Fund Summary Prospectus (497k)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
01/04/2014	15:42	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
01/04/2014	15:37	Edgar (US Regulatory)	Definitive Materials Filed by Investment Companies. (497)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)